We are live on ! Find out more
CGEM icon

Cullinan Oncology
CGEM

97 hedge funds and large institutions have $396M invested in Cullinan Oncology in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 43 increasing their positions, 22 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more call options, than puts

Call options by funds: $13K | Put options by funds: $3K

95% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 22

1.19% more ownership

Funds ownership: 81.18% → 82.37% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

8% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 13

2% less funds holding

Funds holding: 99 → 97 (-2)

15% less capital invested

Capital invested by funds: $467M → $396M (-$70.4M)

Holders
97
Holders Change
-2
Holders Change %
-2.02%
% of All Funds
1.56%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
12
Increased
43
Reduced
22
Closed
13
Calls
$13K
Puts
$3K
Net Calls
+$10K
Net Calls Change
-$492K

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$2.38M
2
American Century Companies
American Century Companies
Missouri
+$2.27M
3
TCM
Tang Capital Management
California
+$2.25M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.75M
5
BlackRock
BlackRock
New York
+$1.6M

Top Sellers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
-$5.51M
2
Goldman Sachs
Goldman Sachs
New York
-$1.93M
3
EC
EcoR1 Capital
California
-$1.31M
4
Morgan Stanley
Morgan Stanley
New York
-$768K
5
Marshall Wace
Marshall Wace
United Kingdom
-$520K
Name Holding Trade Value Shares
Change 		Change in
Stake
MB
1
MPM BioImpact
Massachusetts
$80.7M – – –
BI
2
BVF Inc
California
$79.2M – – –
CA
3
CHI Advisors
New York
$35M +$903K +74,359 +2%
Vanguard Group
4
Vanguard Group
Pennsylvania
$29.7M +$583K +47,960 +2%
BlackRock
5
BlackRock
New York
$26.4M +$1.6M +131,390 +6%
AIG
6
American International Group
New York
$13.1M -$644 -53 -0%
NI
7
Nextech Invest
Switzerland
$12.9M – – –
BC
8
Boxer Capital
California
$11.3M – – –
EC
9
EcoR1 Capital
California
$10.9M -$1.31M -108,180 -9%
TCM
10
Tang Capital Management
California
$8.54M +$2.25M +185,215 +30%
Franklin Resources
11
Franklin Resources
California
$8.25M -$37.6K -3,093 -0.4%
O
12
OrbiMed
New York
$6.72M – – –
RCMNY
13
Rubric Capital Management (New York)
New York
$6.61M +$816K +67,192 +12%
KCM
14
Kennedy Capital Management
Missouri
$6.47M -$308K -25,321 -4%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$5.88M +$189K +15,588 +3%
State Street
16
State Street
Massachusetts
$5.85M +$642K +52,835 +11%
Renaissance Technologies
17
Renaissance Technologies
New York
$3.25M +$66.9K +5,505 +2%
Northern Trust
18
Northern Trust
Illinois
$3.05M +$184K +15,152 +6%
American Century Companies
19
American Century Companies
Missouri
$2.81M +$2.27M +187,249 +237%
AG
20
Artal Group
Luxembourg
$2.64M – – –
Citadel Advisors
21
Citadel Advisors
Florida
$2.59M +$115K +9,507 +4%
SCM
22
Silverarc Capital Management
Massachusetts
$2.42M +$59K +4,861 +2%
Morgan Stanley
23
Morgan Stanley
New York
$2.37M -$768K -63,262 -22%
Charles Schwab
24
Charles Schwab
California
$2.33M +$36.8K +3,028 +1%
Millennium Management
25
Millennium Management
New York
$2.26M +$788K +64,862 +43%
1
2 3 4 5

CGEM Hedge Fund Activity: Q4 2022 in Review

97 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Cullinan Oncology (CGEM) for Q4 2022, worth a combined $396M — down 15% from $467M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of CGEM and 12 opened new positions — a net loss of 1 holder — while 22 trimmed existing stakes and 43 added.

The largest buyer was Woodline Partners, opening a new position worth an estimated $2.38M. The largest seller was Baupost Group, exiting entirely with an estimated $5.51M sold.

  • 97 institutional investors held Cullinan Oncology (CGEM) as of Q4 2022, down from 99 in Q3 2022.
  • Funds reported $396M of Cullinan Oncology stock for Q4 2022, down 15% quarter-over-quarter.
  • 12 funds opened new Cullinan Oncology positions in Q4 2022 and 13 closed out, a net change of -1 holder.
  • The largest Cullinan Oncology buyer in Q4 2022 was Woodline Partners, an estimated $2.38M added.
  • The largest Cullinan Oncology seller in Q4 2022 was Baupost Group, an estimated $5.51M sold.

Based on aggregated 13F filings for Q4 2022.